{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:33:41Z","timestamp":1783474421891,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,10]]},"DOI":"10.7759\/cureus.69079","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:56:29Z","timestamp":1725972989000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Anaphylaxis From Remimazolam in a Mastocytosis Cancer Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Julie","family":"Mani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Strang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel A","family":"Faruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhair A","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.17085\/apm.21115","article-title":"Remimazolam: pharmacological characteristics and clinical applications in anesthesiology","volume":"17","author":"Kim KM","year":"2022","unstructured":"Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul). 2022, 17:1-11. 10.17085\/apm.21115","journal-title":"Anesth Pain Med (Seoul)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/1658-354X.136627","article-title":"Remimazolam: the future of its sedative potential","volume":"8","author":"Goudra BG","year":"2014","unstructured":"Goudra BG, Singh PM. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014, 8:388-91. 10.4103\/1658-354X.136627","journal-title":"Saudi J Anaesth"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.6859\/aja.202306_61(2).0001","article-title":"A narrative review of remimazolam in procedural sedation","volume":"61","author":"Chen GC","year":"2023","unstructured":"Chen GC, Lin SS, Lin PA, Tseng WC, Lu CH. A narrative review of remimazolam in procedural sedation. Asian J Anesthesiol. 2023, 61:39-45. 10.6859\/aja.202306_61(2).0001","journal-title":"Asian J Anesthesiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S375957","article-title":"Profile of remimazolam in anesthesiology: a narrative review of clinical research progress","volume":"16","author":"Wang M","year":"2022","unstructured":"Wang M, Zhao X, Yin P, Bao X, Tang H, Kang X. Profile of remimazolam in anesthesiology: a narrative review of clinical research progress. Drug Des Devel Ther. 2022, 16:3431-44. 10.2147\/DDDT.S375957","journal-title":"Drug Des Devel Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23736\/S0375-9393.22.16631-9","article-title":"Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes","volume":"88","author":"Tang Y","year":"2022","unstructured":"Tang Y, Yang X, Yu Y, et al.. Remimazolam versus traditional sedatives for procedural sedation: a systematic review and meta-analysis of efficacy and safety outcomes. Minerva Anestesiol. 2022, 88:939-49. 10.23736\/S0375-9393.22.16631-9","journal-title":"Minerva Anestesiol"},{"key":"ref6","article-title":"","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. Bethesda National Institute of Diabetes and Digestive and Kidney Diseases, 2012. https:\/\/pubmed.ncbi.nlm.nih.gov\/31643176\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59111915","article-title":"Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test-A Case Report and Literature Review","volume":"59","author":"Lee S","year":"2023","unstructured":"Lee S, Park J, Kim NH, et al.. Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test-A Case Report and Literature Review. Medicina (Kaunas). 2023, 59:59. 10.3390\/medicina59111915","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08874-1","article-title":"Perioperative anaphylaxis: evaluation and management","volume":"62","author":"Manian DV","year":"2022","unstructured":"Manian DV, Volcheck GW. Perioperative anaphylaxis: evaluation and management. Clin Rev Allergy Immunol. 2022, 62:383-99. 10.1007\/s12016-021-08874-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000004419","article-title":"Perioperative anaphylaxis","volume":"138","author":"Tacquard C","year":"2023","unstructured":"Tacquard C, Iba T, Levy JH. Perioperative anaphylaxis. Anesthesiology. 2023, 138:100-10. 10.1097\/ALN.0000000000004419","journal-title":"Anesthesiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2006.01.006","article-title":"Anaphylactoid reactions to dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004","volume":"43","author":"Zinderman CE","year":"2006","unstructured":"Zinderman CE, Landow L, Wise RP. Anaphylactoid reactions to dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004. J Vasc Surg. 2006, 43:1004-9. 10.1016\/j.jvs.2006.01.006","journal-title":"J Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001616","article-title":"Cardiac arrest following remimazolam-induced anaphylaxis: a case report","volume":"16","author":"Hasushita Y","year":"2022","unstructured":"Hasushita Y, Nagao M, Miyazawa Y, Yunoki K, Mima H. Cardiac arrest following remimazolam-induced anaphylaxis: a case report. A A Pract. 2022, 16:e01616. 10.1213\/XAA.0000000000001616","journal-title":"A A Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.063","article-title":"Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A\u00a0Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology","volume":"143","author":"Carter MC","year":"2019","unstructured":"Carter MC, Metcalfe DD, Matito A, et al.. Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A\u00a0Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2019, 143:880-93. 10.1016\/j.jaci.2018.10.063","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000031","article-title":"Perioperative management of patients with mastocytosis","volume":"120","author":"Dewachter P","year":"2014","unstructured":"Dewachter P, Castells MC, Hepner DL, Mouton-Faivre C. Perioperative management of patients with mastocytosis. Anesthesiology. 2014, 120:753-9. 10.1097\/ALN.0000000000000031","journal-title":"Anesthesiology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000436969","article-title":"Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish Network on mastocytosis (REMA) based on 726 anesthetic procedures","volume":"167","author":"Matito A","year":"2015","unstructured":"Matito A, Morgado JM, S\u00e1nchez-L\u00f3pez P, \u00c1lvarez-Twose I, S\u00e1nchez-Mu\u00f1oz L, Orfao A, Escribano L. Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish Network on mastocytosis (REMA) based on 726 anesthetic procedures. Int Arch Allergy Immunol. 2015, 167:47-56. 10.1159\/000436969","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/268014-severe-anaphylaxis-from-remimazolam-in-a-mastocytosis-cancer-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:56:34Z","timestamp":1725972994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/268014-severe-anaphylaxis-from-remimazolam-in-a-mastocytosis-cancer-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.69079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,10]]}}}